We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$112B
AUM Growth
+$1.24B
Cap. Flow
-$4.67B
Cap. Flow %
-4.16%
Top 10 Hldgs %
33.05%
Holding
7,587
New
332
Increased
2,155
Reduced
4,171
Closed
298

Sector Composition

Rank Sector Weight
1 Financials 4.53%
2 Energy 3.9%
3 Technology 3.29%
4 Healthcare 2.41%
5 Industrials 2.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYL icon
7226
CALL
Xylem
XYL
$28.7B
-7,000
Closed -$347K
YPF icon
7227
CALL
YPF
YPF
$19.9B
-7,300
Closed -$120K
YPF icon
7228
PUT
YPF
YPF
$19.9B
-2,300
Closed -$38K
ZUMZ icon
7229
CALL
Zumiez
ZUMZ
$325M
-2,200
Closed -$48K
NAGE
7230
Niagen Bioscience
NAGE
$259M
$0 ﹤0.01%
83
-28,723
-100% -$81.5K
VIRX
7231
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-28
Closed -$4K
AUMN
7232
DELISTED
Golden Minerals Company
AUMN
$0 ﹤0.01%
1
SAVE
7233
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
-900
Closed -$52K
SAVE
7234
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
-3,200
Closed -$185K
ASXC
7235
PUT
DELISTED
Asensus Surgical, Inc.
ASXC
-77
Closed -$1K
GENE
7236
DELISTED
Genetic Technologies Ltd.
GENE
$0 ﹤0.01%
15
FPL
7237
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
-11,048
Closed -$142K
FIF
7238
DELISTED
FIRST TRUST ENERGY INFRASTRUCTURE FUND
FIF
-3,704
Closed -$67K
YTEN
7239
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
0
CBD
7240
DELISTED
Companhia Brasileira de Distribuicao
CBD
-400
Closed -$7K
EXPR
7241
PUT
DELISTED
Express, Inc.
EXPR
-250
Closed -$54K
BPTH
7242
DELISTED
Bio-Path Holdings Inc
BPTH
-22
Closed -$79.9K
ONCT
7243
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$0 ﹤0.01%
1
SGEN
7244
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
-6,000
Closed -$317K
AVTA
7245
CALL
DELISTED
Avantax, Inc. Common Stock
AVTA
-700
Closed -$10K
AVTA
7246
PUT
DELISTED
Avantax, Inc. Common Stock
AVTA
-5,100
Closed -$75K
FDEU
7247
DELISTED
First Trust Dynamic Europe Equity Income Fund
FDEU
-145,245
Closed -$2.25M
AVID
7248
DELISTED
Avid Technology Inc
AVID
$0 ﹤0.01%
104
-39,158
-100% -$202K
FRGI
7249
CALL
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
-33,900
Closed -$1.01M
BKI
7250
DELISTED
Black Knight, Inc. Common Stock
BKI
-5
Closed

Similar funds

Citigroup's Q1 2017 Portfolio in Review

As of Q1 2017, Citigroup held 7,587 positions worth $112B, up 1.1% from $111B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Citigroup withdrew a net $4.67B in Q1 2017, closing 298 positions and reducing 4,171 holdings. Its most notable exit was St Jude Medical, an estimated $368M position sold in full.

By sector, the portfolio is most concentrated in Financials at 4.5% of assets, down from 5% a quarter earlier, followed by Energy and Technology.

Against the trend, Citigroup opened a new position in Kayne Anderson Acquisition Corp. Unit worth $25.1M.

  • Citigroup's largest Q1 2017 buy was Kayne Anderson Acquisition Corp. Unit: 2,500,000 shares worth $25.1M.
  • Citigroup added most to Walt Disney in Q1 2017, an estimated $358M increase.
  • Citigroup's biggest Q1 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $1.61B.
  • Citigroup fully exited St Jude Medical in Q1 2017, selling an estimated $368M.
  • Citigroup's ten largest holdings make up 33% of its $112B portfolio in Q1 2017.
  • Citigroup opened 332 new positions and closed 298 in Q1 2017.
  • Citigroup's portfolio value rose 1.1% quarter-over-quarter to $112B.

Based on Citigroup's 13F filing for Q1 2017, filed 12 May 2017.